Publication Name	World Journal of Gastroenterology
Manuscript ID	6597
Country	Italy

Received	2013-10-25 11:48
Peer-Review Started	2013-10-25 19:27
To Make the First Decision	2013-11-13 13:38
Return for Revision	2013-11-14 12:23
Revised	2013-11-29 01:27
Second Decision	2014-01-20 17:08
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-01-20 18:11
Articles in Press	2014-05-23 11:36
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-04-07 04:44
Typeset the Manuscript	2014-05-26 10:07
Publish the Manuscript Online	2014-06-16 16:19

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma
Manuscript Source	Invited Manuscript
All Author List	Maria Caterina Pallotti, Margherita Nannini, Claudio Agostinelli, Simona Leoni, Valerio Di Scioscio, Anna Mandrioli, Cristian Lolli, Maristella Saponara, Stefano Pileri, Luigi Bolondi, Guido Biasco and Maria Abbondanza Pantaleo
Funding Agency and Grant Number
Corresponding Author	Maria Caterina Pallotti, MD, Department of Specialized, Experimental, and Diagnostic Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy. mcaterinapallotti@gmail.com
Key Words	Hepatic epithelioid hemangioendothelioma; Liver; Lenalidomide; Magnetic resonance; Abdominal ultrasound
Core Tip	Hepatic epithelioid hemangioendothelioma (HEH) is a rare tumor. Currently, no standard medical treatment is indicated in unresectable disease. We describe the case of a patient with HEH who obtained stable disease after 40 mo of treatment with lenalidomide. Tolerance to treatment was very good. This report highlights the possibility of obtaining very long stable disease with an anti-angiogenesis drug. In recent years, the introduction of angiogenesis inhibitors has offered an interesting medical approach to this rare tumor.
Publish Date	2014-06-16 16:19
Citation	Pallotti MC, Nannini M, Agostinelli C, Leoni S, Di Scioscio V, Mandrioli A, Lolli C, Saponara M, Pileri S, Bolondi L, Biasco G, Pantaleo MA. Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma. World J Gastroenterol 2014; 20(22): 7049-7054
URL	http://www.wjgnet.com/1007-9327/full/v20/i22/7049.htm
DOI	10.3748/wjg.v20.i22.7049

Full Article (PDF)	WJG-20-7049.pdf
Full Article (Word)	WJG-20-7049.doc
Manuscript File	6597-Review.doc
Answering Reviewers	6597-Answering reviewers.pdf
Copyright License Agreement	6597-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	6597-Language certificate.pdf
Peer-review Report	6597-Peer review(s).pdf
Scientific Editor Work List	6597-Scientific editor work list.doc